Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Harrach
MATE1 Regulates Cellular Uptake and Sensitivity to Imatinib in CML Patients
Blood Cancer Journal
Oncology
Hematology
Related publications
CML: Langzeitresultate Zum Imatinib-Stopp
Im Focus Onkologie
The EUTOS Prognostic Score: Review and Validation in 1288 Patients With CML Treated Frontline With Imatinib
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Downregulation of Γ-Catenin Inhibits CML Cell Growth and Potentiates the Response of CML Cells to Imatinib Through Β-Catenin Inhibition
International Journal of Molecular Medicine
Medicine
Genetics
Efficacy and Safety of Imatinib in Paediatric CML – A Single Centre Study
In Vivo
Biochemistry
Medicine
Genetics
Pharmacology
Molecular Biology
Lonafarnib Reduces the Resistance of Primitive Quiescent CML Cells to Imatinib Mesylate in Vitro
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
A Novel BCR-Abl Splice Isoform Is Associated With the L248V Mutation in CML Patients With Acquired Resistance to Imatinib
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
EVI-1 Oncogene Expression Predicts Survival in Chronic-Phase CML Patients Resistant to Imatinib Treated With Second-Generation Tyrosine Kinase Inhibitors
Blood
Biochemistry
Immunology
Cell Biology
Hematology
CXCR4 Up-Regulation by Imatinib Induces Chronic Myelogenous Leukemia (CML) Cell Migration to Bone Marrow Stroma and Promotes Survival of Quiescent CML Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
Berbamine Exhibits Potent Antitumor Effects on Imatinib-Resistant CML Cells in Vitro and in Vivo
Acta Pharmacologica Sinica
Medicine
Pharmacology
